These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2563231)

  • 1. Increased saccadic distractibility in tardive dyskinesia: functional evidence for subcortical GABA dysfunction.
    Thaker GK; Nguyen JA; Tamminga CA
    Biol Psychiatry; 1989 Jan; 25(1):49-59. PubMed ID: 2563231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA agonist-induced changes in motor, oculomotor, and attention measures correlate in schizophrenics with tardive dyskinesia.
    Cassady SL; Thaker GK; Moran M; Birt A; Tamminga CA
    Biol Psychiatry; 1992 Aug; 32(4):302-11. PubMed ID: 1358231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saccadic distractibility in schizophrenic patients with tardive dyskinesia.
    Thaker GK; Nguyen JA; Tamminga CA
    Arch Gen Psychiatry; 1989 Aug; 46(8):755-6. PubMed ID: 2568826
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of tardive dyskinesia with increased frequency of eye movement disturbances in chronic schizophrenic patients. A clinical note.
    Oepen G; Thoden U; Warmke C
    Eur Arch Psychiatry Neurol Sci; 1990; 239(4):241-5. PubMed ID: 1969345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic relationship of antisaccade and dyskinesia in schizophrenic patients.
    Cassady SL; Thaker GK; Tamminga CA
    Psychopharmacol Bull; 1993; 29(2):235-40. PubMed ID: 8290671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of saccadic eye movements by GABA-related substances. II. Effects of muscimol in monkey substantia nigra pars reticulata.
    Hikosaka O; Wurtz RH
    J Neurophysiol; 1985 Jan; 53(1):292-308. PubMed ID: 2983038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of neuroleptics and tardive dyskinesia on smooth-pursuit eye movement in chronic schizophrenics.
    Spohn HE; Coyne L; Spray J
    Arch Gen Psychiatry; 1988 Sep; 45(9):833-40. PubMed ID: 2901252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI abnormalities in tardive dyskinesia.
    Mion CC; Andreasen NC; Arndt S; Swayze VW; Cohen GA
    Psychiatry Res; 1991 Nov; 40(3):157-66. PubMed ID: 1685788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between smooth pursuit eye movements and tardive dyskinesia in schizophrenia.
    Ross DE; Buchanan RW; Lahti AC; Medoff D; Bartko JJ; Compton AD; Thaker GK
    Schizophr Res; 1998 May; 31(2-3):141-50. PubMed ID: 9689718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI in tardive dyskinesia: shortened left caudate T2.
    Bartzokis G; Garber HJ; Marder SR; Olendorf WH
    Biol Psychiatry; 1990 Dec; 28(12):1027-36. PubMed ID: 1981152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia.
    Gerlach J; Casey DE
    Acta Psychiatr Scand; 1988 Apr; 77(4):369-78. PubMed ID: 2898870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone treatment of tardive dyskinesia in patients with schizophrenia.
    Wonodi I; Adami H; Sherr J; Avila M; Hong LE; Thaker GK
    J Clin Psychopharmacol; 2004 Aug; 24(4):441-5. PubMed ID: 15232337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does pursuit abnormality in schizophrenia represent a deficit in the predictive mechanism?
    Thaker GK; Ross DE; Buchanan RW; Moran MJ; Lahti A; Kim C; Medoff D
    Psychiatry Res; 1996 Jan; 59(3):221-37. PubMed ID: 8930028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saccadic abnormalities in psychotic patients. II. The role of neuroleptic treatment.
    Crawford TJ; Haeger B; Kennard C; Reveley MA; Henderson L
    Psychol Med; 1995 May; 25(3):473-83. PubMed ID: 7480428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron-emission tomography in tardive dyskinesia.
    Pahl JJ; Mazziotta JC; Bartzokis G; Cummings J; Altschuler L; Mintz J; Marder SR; Phelps ME
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):457-65. PubMed ID: 8555748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.
    Spohn HE; Coyne L; Lacoursiere R; Mazur D; Hayes K
    Arch Gen Psychiatry; 1985 Sep; 42(9):849-59. PubMed ID: 2864028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomically distinct output channels of the caudate nucleus and orofacial dyskinesia: critical role of the subcommissural part of the globus pallidus in oral dyskinesia.
    Cools AR; Spooren W; Bezemer R; Cuypers E; Jaspers R; Groenewegen H
    Neuroscience; 1989; 33(3):535-42. PubMed ID: 2561520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal ganglia T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia.
    Buckley P; O'Callaghan E; Mulvany F; Larkin C; Stack JP; Redmond O; Ennis JT; Thompson P; Waddington JL
    Psychiatry Res; 1995 Aug; 61(2):95-102. PubMed ID: 7480392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
    McCormick SE; Stoessl AJ
    Neuroscience; 2003; 119(2):547-55. PubMed ID: 12770567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.